SGL Investment Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.06M Sell
3,215
-25
-0.8% -$8.91K 0.4% 56
2025
Q4
$1.19M Buy
3,240
+39
+1% +$12.4K 0.48% 47
2025
Q3
$948K Buy
3,201
+1,101
+52% +$319K 0.4% 48
2025
Q2
$624K Buy
2,100
+29
+1% +$8.22K 0.3% 67
2025
Q1
$563K Sell
2,071
-62
-3% -$18.3K 0.29% 67
2024
Q4
$629K Sell
2,133
-535
-20% -$159K 0.32% 63
2024
Q3
$790K Buy
+2,668
New +$873K 0.41% 48

Other funds holding AMGN

SGL Investment Advisors's AMGN Position: Q1 2026 in Review

SGL Investment Advisors reduced its Amgen (AMGN) stake by 0.77% in Q1 2026, selling an estimated $8.91K and leaving 3,215 shares worth $1.06M. The position accounts for 0.4% of the portfolio, ranked #56.

SGL Investment Advisors first reported a position in AMGN in Q3 2024 and has held it in 7 quarters since. The position peaked at $1.19M in Q4 2025. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • SGL Investment Advisors held 3,215 shares of Amgen worth $1.06M as of Q1 2026.
  • SGL Investment Advisors sold 25 Amgen shares in Q1 2026, an estimated $8.91K.
  • Amgen made up 0.4% of SGL Investment Advisors's portfolio in Q1 2026, its #56 holding.
  • SGL Investment Advisors first reported a position in Amgen in Q3 2024 and has held it in 7 quarters since.
  • SGL Investment Advisors's Amgen position peaked at $1.19M in Q4 2025.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on SGL Investment Advisors's 13F filing for Q1 2026, filed 12 May 2026.